Pichia 2022 Conference
15th – 17th November 2022

The Pichia 2022 conference and the hands-on course will take place in November in Graz, Austria.

Topics of interest

  • Food & Feed Products
  • Pharmaceutical Products
  • (Bio-) Materials
  • (Bio-) Chemicals
  • Genomics, Transcriptomics, Proteomics, Metabolomics
  • Host strain engineering
  • Vector engineering
  • High Throughput Technologies
  • Latest GRAS & FDA Approvals
  • (Continuous) Bioprocesses (Up- and Down-stream)
  • Databases and digital technologies

Hands-On-Pichia-Lab course
from November 10th to 12th 2022

logo_doppler

This conference will be organized by the “Christian Doppler Laboratory for Innovative Pichia pastoris Host and Vector systems” (TU Graz) and the Christian Doppler-Laboratory for Growth Decoupled Protein Production in Yeast” (BOKU Vienna) in collaboration with the Austrian Centre for Industrial Biotechnology (acib GmbH). Experts will explain and demonstrate the efficient use of the Pichia pastoris (Komagataella phaffii) expression and production system. This course will take place in Graz, Austria.

acib_logo

Pichia Conference
Tuesday, 15th November 2022

13:30 – 15:30

Pichia Session


More information is coming soon …

16:00 – 18:00

Pichia conference

More information is coming soon …

21:00

Chilling Life Science (Dom im Berg)

Pichia Conference
Wednesday, 16th November 2022

10:00 – 12:00

Pichia conference


More information is coming soon …

14:00 – 16:00

Pichia Session


More information is coming soon …

16:30 – 18:00

Pichia Session


More information is coming soon …

19:00

Pichia Dinner powered by Validogen

Sponsored by

VALIDOGEN, a leading Austrian contract research and development company, offers UNLOCK PICHIA – the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein expression/production. VALIDOGEN has established a broad range of exclusive tools and know-how for the generation of high-performance Pichia protein production strains and processes.

Research Corporation Technologies (RCT) in Tucson, Ariz., is a technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. Through its technology licensing program, RCT offers the Pichia Classic and Pichia GlycoSwitch® Systems. The Pichia Classic System is the most cost-effective eukaryotic protein expression system for both secretion and intracellular expression. The Picha GlycoSwitch® System is based on yeast strains that have been engineered to perform specific glycosylation steps at high fidelity. For more information visit www.pichia.com

Modern Meadow is a purpose-driven protein application powerhouse on a mission to be a catalyst for real-world impact on people and the planet. Modern Meadow uses their innovative Bio-Alloy™ and Bio-F@rm™ technology platforms to harness the unique properties of proteins to move the world away from petrochemical and animal-derived inputs without sacrificing material or ingredient performance. Modern Meadow outputs are 100% traceable from Lab-to-Brand™. To learn more about Modern Meadow, please visit www.modernmeadow.com.

Other Sponsors

Bionet is a leading provider of bioprocessing technology and services. We are thrilled to accompany our biotech clients from the R&D to the industrial production settings with the ultimate goal to achieve the productivity and profitability goals of their bioprocesses. We do this through a focused range of equipment and services.

Neochromosome provides synthetic DNA and cell engineering services to investigate novel therapeutics, develop more sustainable products and conduct otherwise unapproachable research. DNA of any size or complexity synthesized in NYC and shipped globally.